Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 1
1968 4
1969 5
1970 3
1971 7
1972 3
1973 12
1974 10
1975 4
1976 8
1977 11
1978 6
1979 4
1980 12
1981 9
1982 11
1983 18
1984 9
1985 17
1986 21
1987 24
1988 19
1989 40
1990 39
1991 46
1992 42
1993 51
1994 41
1995 63
1996 55
1997 50
1998 50
1999 51
2000 74
2001 62
2002 71
2003 75
2004 89
2005 67
2006 75
2007 84
2008 87
2009 84
2010 98
2011 77
2012 127
2013 138
2014 126
2015 160
2016 176
2017 171
2018 149
2019 169
2020 189
2021 194
2022 169
2023 203
2024 82

Text availability

Article attribute

Article type

Publication date

Search Results

3,323 results

Results by year

Filters applied: . Clear all
Page 1
Systemic sclerosis-associated interstitial lung disease.
Perelas A, Silver RM, Arrossi AV, Highland KB. Perelas A, et al. Lancet Respir Med. 2020 Mar;8(3):304-320. doi: 10.1016/S2213-2600(19)30480-1. Epub 2020 Feb 27. Lancet Respir Med. 2020. PMID: 32113575 Review.
Interstitial lung disease is more common among African Americans and in people with the diffuse cutaneous form of systemic sclerosis or anti-topoisomerase 1 antibodies. Systemic sclerosis-associated interstitial lung disease most c …
Interstitial lung disease is more common among African Americans and in people with the diffuse cutaneous form of syste …
Progressive pulmonary fibrosis: an expert group consensus statement.
Rajan SK, Cottin V, Dhar R, Danoff S, Flaherty KR, Brown KK, Mohan A, Renzoni E, Mohan M, Udwadia Z, Shenoy P, Currow D, Devraj A, Jankharia B, Kulshrestha R, Jones S, Ravaglia C, Quadrelli S, Iyer R, Dhooria S, Kolb M, Wells AU. Rajan SK, et al. Eur Respir J. 2023 Mar 30;61(3):2103187. doi: 10.1183/13993003.03187-2021. Print 2023 Mar. Eur Respir J. 2023. PMID: 36517177 Free PMC article. Review.
This expert group consensus statement emphasises the need for standardising the definition of progressive fibrosing interstitial lung diseases (F-ILDs), with an accurate initial diagnosis being of paramount importance in ensuring appropriate initial managemen …
This expert group consensus statement emphasises the need for standardising the definition of progressive fibrosing interstitial l …
Progressive pulmonary fibrosis (PPF).
Duman D. Duman D. Tuberk Toraks. 2022 Dec;70(4):375-381. doi: 10.5578/tt.20229609. Tuberk Toraks. 2022. PMID: 36537095 Free article. Review. English.
Progressive pulmonary fibrosis (PPF) is defined as the presence of at least two of the three criteria, which are worsening respiratory symptoms, functional decline, and radiological progression in patients with interstitial lung disease with radiological pulm …
Progressive pulmonary fibrosis (PPF) is defined as the presence of at least two of the three criteria, which are worsening respiratory sympt …
Management of Myositis-Associated Interstitial Lung Disease.
Fujisawa T. Fujisawa T. Medicina (Kaunas). 2021 Apr 3;57(4):347. doi: 10.3390/medicina57040347. Medicina (Kaunas). 2021. PMID: 33916864 Free PMC article. Review.
Idiopathic inflammatory myopathies, including polymyositis (PM), dermatomyositis (DM), and clinically amyopathic DM (CADM), are a diverse group of autoimmune diseases characterized by muscular involvement and extramuscular manifestations. Interstitial lung …
Idiopathic inflammatory myopathies, including polymyositis (PM), dermatomyositis (DM), and clinically amyopathic DM (CADM), are a diverse gr …
Pulmonary hypertension in chronic lung disease and hypoxia.
Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, Olsson KM, Peacock AJ, Pepke-Zaba J, Provencher S, Weissmann N, Seeger W. Nathan SD, et al. Eur Respir J. 2019 Jan 24;53(1):1801914. doi: 10.1183/13993003.01914-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30545980 Free PMC article. Review.
Pulmonary hypertension (PH) frequently complicates the course of patients with various forms of chronic lung disease (CLD). CLD-associated PH (CLD-PH) is invariably associated with reduced functional ability, impaired quality of life, greater oxygen requirements and …
Pulmonary hypertension (PH) frequently complicates the course of patients with various forms of chronic lung disease (CLD). CL …
Myositis Antibodies and Interstitial Lung Disease.
Basuita M, Fidler LM. Basuita M, et al. J Appl Lab Med. 2022 Jan 5;7(1):240-258. doi: 10.1093/jalm/jfab108. J Appl Lab Med. 2022. PMID: 34996093 Free article. Review.
BACKGROUND: Interstitial lung disease (ILD) comprises a heterogeneous group of inflammatory and fibrotic conditions, often resulting in progressive lung function decline and increased mortality. Connective tissue disease (CTD) should be consider …
BACKGROUND: Interstitial lung disease (ILD) comprises a heterogeneous group of inflammatory and fibrotic conditions, of …
Acute exacerbation of interstitial lung disease associated with rheumatic disease.
Luppi F, Sebastiani M, Salvarani C, Bendstrup E, Manfredi A. Luppi F, et al. Nat Rev Rheumatol. 2022 Feb;18(2):85-96. doi: 10.1038/s41584-021-00721-z. Epub 2021 Dec 7. Nat Rev Rheumatol. 2022. PMID: 34876670 Review.
Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis. Some patients with ILD secondary to rheumatic disease …
Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic diseases, such …
Pulmonary fibrosis: from pathogenesis to clinical decision-making.
Koudstaal T, Funke-Chambour M, Kreuter M, Molyneaux PL, Wijsenbeek MS. Koudstaal T, et al. Trends Mol Med. 2023 Dec;29(12):1076-1087. doi: 10.1016/j.molmed.2023.08.010. Epub 2023 Sep 14. Trends Mol Med. 2023. PMID: 37716906 Review.
Pulmonary fibrosis (PF) encompasses a spectrum of chronic lung diseases that progressively impact the interstitium, resulting in compromised gas exchange, breathlessness, diminished quality of life (QoL), and ultimately respiratory failure and mortality. Various …
Pulmonary fibrosis (PF) encompasses a spectrum of chronic lung diseases that progressively impact the interstitium, resulting …
Clinical manifestations and treatment of antisynthetase syndrome.
Marco JL, Collins BF. Marco JL, et al. Best Pract Res Clin Rheumatol. 2020 Aug;34(4):101503. doi: 10.1016/j.berh.2020.101503. Epub 2020 Apr 11. Best Pract Res Clin Rheumatol. 2020. PMID: 32284267 Review.
Antisynthetase syndrome (ASyS) is an autoimmune disease clinically manifested most often by interstitial lung disease, myositis, and arthritis. ...We discuss the spectrum of disease seen with specific antisynthetase antibodies and examine the di …
Antisynthetase syndrome (ASyS) is an autoimmune disease clinically manifested most often by interstitial lung diseas …
Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review.
McPherson M, Economidou S, Liampas A, Zis P, Parperis K. McPherson M, et al. Semin Arthritis Rheum. 2022 Apr;53:151959. doi: 10.1016/j.semarthrit.2022.151959. Epub 2022 Jan 31. Semin Arthritis Rheum. 2022. PMID: 35134633 Review.
INTRODUCTION: Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive clinically amyopathic dermatomyositis (CADM) is frequently associated with rapidly progressive interstitial lung disease (RP-ILD) and high mortality rates. There is a lack …
INTRODUCTION: Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive clinically amyopathic dermatomyositis (CADM) is frequ …
3,323 results